Summary:
Click image to enlarge
Metabolically dysfunction-associated steatohepatitis (MASH) is a progressive form of fatty liver disease. It occurs when fat builds up in the liver (a condition known as steatosis) and is accompanied by inflammation and liver cell damage. This condition is part of a broader spectrum of liver diseases linked to metabolic dysfunction, including obesity, type 2 diabetes, high cholesterol, and insulin resistance. MASH was previously referred to as nonalcoholic steatohepatitis (NASH) but has recently been renamed to better reflect its association with metabolic health rather than alcohol use. We’re looking for patient volunteers to help assess the effectiveness of a new medication for this condition. The medication is provided at no cost to you or your insurance, and you will be compensated for your time and travel. Plus, if you refer a friend who qualifies, you can earn a $100 BONUS! Don’t miss this opportunity!
Qualified Participants Must:
• Must be 18 years or older
•
Diagnosed with a liver condition called MASH
Qualified Participants May Receive:
- Compensation: Get compensated up to $100 per clinical visit with no cost to you or your insurance!
- Comprehensive Support: Regular check-ins and assessments to ensure your health is a priority. Our trial is conducted by experienced healthcare professionals dedicated to your well-being.
- Free study medications: Study medication for Steatohepatitis (MASH) is given at no cost